OncoZenge AB Enters into Collaboration with UCLA for Patient Engagement Study on BupiZenge™

STOCKHOLM, Sept. 17, 2025 /PRNewswire/ -- OncoZenge AB (publ) ("OncoZenge" or "the Company"), a pharmaceutical company developing an innovative treatment for oral pain relief, today announced a new collaboration with the University of California, Los Angeles (UCLA). The partnership...